Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

布兰德·普洛特尼克与MRI 筛查 在 2021 年被诊断为乳腺癌后，Brand 成为了早期 MRI 筛查、乳房切除术后的美学平坦闭合以及癌后健康改善的重要倡导者。越早进行 MRI 筛查，就能越早为健康做好全面的规划。

AI 助力医疗保健行业和诊断成像的创新 创新是博莱科核心业务的重要驱动力，公司多次邀请专家探讨人工智能（AI）如何帮助加速药物研发并提高诊断准确性。未来，医疗行业和全人类将从人工智能和机器学习中获益良多。

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

博莱科持续创新：拥抱精准医疗时代 探索博莱科参与 ECR 2024 欧洲放射学大会的活动行程表（2024年2月28日-3月3日），与全球优秀的医学专家们一起探讨CT造影剂优化，以及诊断成像的未来。

博莱科如何在 2023 年达到新的高度 MRI、可持续性和教育的创新 Bracco Diagnostics Inc. 销售和营销高级副总裁 Cosimo De Pinto 在RSNA 2023北美放射学会后接受采访，盛赞VUEWAY™造影剂、AI医疗成像创新和支持教育使博莱科达到新高度。

Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.

博莱科赋予教育什么价值？ 在ECR2024会议上，与Bracco Imaging全球营销战略和运营总监Francesca Pelliconi对话，她分享了博莱科对于教育的投入和承诺，将继续培养和优先考虑教育和知识共享的传统。

The Bracco Group announces the newly-created Bracco Japan The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai